Corbus Pharmaceuticals Holdings Inc's Company Valuation
Currency: USD Updated: 2026-06-18
Previous score
7.09
Change
0
The current valuation score of Corbus Pharmaceuticals Holdings Inc is 7.09, ranking 263 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.44, which is -99.51% below the recent high of -0.01 and -639.16% above the recent low of -10.65.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.